Paper42497201
Antimalarial cytoskeletal targeting with broad apicomplexan activity.
Trivedi DV and 41 others. Proc Natl Acad Sci U S A, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Antimalarial cytoskeletal targeting with broad apicomplexan activity. Papers, record 42497201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42497201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Plasmodium falciparum | Major topic |
| Antimalarials | Major topic |
| Cytoskeleton | Major topic |
| Nonmuscle Myosin Type IIA | Major topic |
| Animals | |
| Humans | |
| Protozoan Proteins | |
| Malaria, Falciparum | |
| Actins |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| INV-035052 | Gates Foundation | United States | PubMed | PubMed | |
| R01 AI132378 | NIAID NIH HHS | United States | R01AI132378 | PubMed | NIH RePORTER |
| RD-16-1066 | Medicines for Malaria Venture (MMV) | PubMed | PubMed | ||
| 2019/19708-0 | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | PubMed | PubMed | ||
| 2024/04805-8 | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | PubMed | PubMed | ||
| INV-035052 | Bill & Melinda Gates Foundation | United States | PubMed | PubMed |
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29970464 | The Actinomyosin Motor Drives Malaria Parasite Red Blood Cell Invasion but Not Egress. | mBio | 2018 | https://conductscience.org/library/papers/29970464 | PubMed |
| 2 | 39196240 | Myosin modulators move forward with FDA approval of mavacamten. | Nat Cardiovasc Res | 2022 | https://conductscience.org/library/papers/39196240 | PubMed |
| 3 | 25278220 | A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. | Lancet Infect Dis | 2015 | https://conductscience.org/library/papers/25278220 | PubMed |
| 4 | 37308472 | Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design. | Nat Commun | 2023 | https://conductscience.org/library/papers/37308472 | PubMed |
| 5 | 21768300 | A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. | Blood | 2011 | https://conductscience.org/library/papers/21768300 | PubMed |
| 6 | 37155705 | MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondii. | PLoS Biol | 2023 | https://conductscience.org/library/papers/37155705 | PubMed |
| 7 | 38421191 | Identification of fungal natural products with potent inhibition in Toxoplasma gondii. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38421191 | PubMed |
| 8 | 22728672 | A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. | Fly (Austin) | 2012 | https://conductscience.org/library/papers/22728672 | PubMed |
| 9 | 25936506 | How actin initiates the motor activity of Myosin. | Dev Cell | 2015 | https://conductscience.org/library/papers/25936506 | PubMed |
| 10 | 781840 | Human malaria parasites in continuous culture. | Science | 1976 | https://conductscience.org/library/papers/781840 | PubMed |
| 11 | 34001441 | Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials. | Trends Parasitol | 2021 | https://conductscience.org/library/papers/34001441 | PubMed |
| 12 | 22383983 | P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action. | PLoS One | 2012 | https://conductscience.org/library/papers/22383983 | PubMed |
| 13 | 25487796 | Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/25487796 | PubMed |
| 14 | 22065754 | Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/22065754 | PubMed |
| 15 | 33954122 | The Ringleaders: Understanding the Apicomplexan Basal Complex Through Comparison to Established Contractile Ring Systems. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/33954122 | PubMed |
| 16 | 31337750 | Plasmodium myosin A drives parasite invasion by an atypical force generating mechanism. | Nat Commun | 2019 | https://conductscience.org/library/papers/31337750 | PubMed |
| 17 | 28978649 | Reconstitution of the core of the malaria parasite glideosome with recombinant Plasmodium class XIV myosin A and Plasmodium actin. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28978649 | PubMed |
| 18 | 17087929 | In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models. | Exp Parasitol | 2007 | https://conductscience.org/library/papers/17087929 | PubMed |
| 19 | 2932435 | Effects of Ca2+ on the conformation and enzymatic activity of smooth muscle myosin. | J Biol Chem | 1985 | https://conductscience.org/library/papers/2932435 | PubMed |
| 20 | 30814727 | Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission. | Nature | 2019 | https://conductscience.org/library/papers/30814727 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797509 | Identification of Small-Molecule Inhibitors of Babesia bovis by High-Throughput SYBR Green I Screening. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797509 | PubMed |
| 42367977 | Identification of UCB-9721 as a potent inhibitor of MyoA, the essential class XIV myosin motor of apicomplexan parasites. | bioRxiv | 2026 | https://conductscience.org/library/papers/42367977 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42497201
GET https://conductscience.org/api/papers/v1/42497201/authors?page=2